Already a Bloomberg.com user?
Sign in with the same account.
Selected settlements of federal cases involving allegations of health-care industry misconduct
PFIZER: $2.3 BILLION
Allegedly promoted unapproved uses for Bextra and other prescription drugs (September 2009)
QUEST DIAGNOSTICS: $302 MILLION
Allegedly sold inaccurate and unreliable laboratory test kits (April 2009)
ELI LILLY: $1.4 BILLION
Purportedly promoted unapproved uses for antipsychotic drug Zyprexa (January 2009)
BAYER HEALTHCARE: $97.5 MILLION
Allegedly paid kickbacks aimed at having patients switched to Bayer products (November 2008)
KYPHON: $75 MILLION
Purportedly persuaded hospitals to overbill for spinal procedures (May 2008)*
* Now owned by Medtronic
Data: U.S. Justice Dept.